Aspirin attenuates spontaneous recurrent seizures and inhibits hippocampal neuronal loss, mossy fiber sprouting and aberrant neurogenesis following pilocarpine-induced status epilepticus in rats

Brain Research

Volumn 1469, Issue , 2012, Pages 103-113

  Ma, Lei ^a   Cui, Xiao Li ^a   Wang, Ying ^a   Li, Xiao Wei ^a   Yang, Feng ^a   Wei, Dong ^a   Jiang, Wen ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Aspirin; Epilepsy; Epileptogenesis; Inflammation; Mossy fiber sprouting; Neurogenesis

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; LITHIUM CHLORIDE; PILOCARPINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MOSSY FIBER; NERVE CELL NECROSIS; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAT; RECURRENT DISEASE; SEIZURE;

ANIMALS; ASPIRIN; CELL DEATH; CELL PROLIFERATION; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; HIPPOCAMPUS; MOSSY FIBERS, HIPPOCAMPAL; NEUROGENESIS; NEURONS; PILOCARPINE; RATS; SEIZURES; STATUS EPILEPTICUS;

RATTUS;

EID: 84864744047     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.05.058     Document Type: Article

References (53)

1. J.A. Aarli Epilepsy and the immune system Arch. Neurol. 57 2000 1689 1692
2. S. Aid, and F. Bosetti Gene expression of cyclooxygenase-1 and Ca(2)-independent phospholipase A(2) is altered in rat hippocampus during normal aging Brain Res. Bull. 73 2007 108 113 (Pubitemid 46710255)
3. M.A. Ajmone-Cat, E. Cacci, and L. Minghetti Non steroidal anti-inflammatory drugs and neurogenesis in the adult mammalian brain Curr. Pharm. Des. 14 2008 1435 1442 (Pubitemid 351982551)
4. E.S. Akarsu, S. Ozdayi, E. Algan, and F. Ulupinar The neuronal excitability time-dependently changes after lipopolysaccharide administration in mice: possible role of cyclooxygenase-2 induction Epilepsy Res. 71 2006 181 187 (Pubitemid 44416195)
5. K.K. Akula, A. Dhir, and S.K. Kulkarni Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: possible involvement of adenosinergic mechanism Epilepsy Res. 78 2008 60 70 (Pubitemid 350296777)
6. F. Antonaci, G. Sances, R. Manni, and M.G. Buzzi Epileptic seizure during aspirin and caffeine withdrawal in a drug induced headache Funct. Neurol. 11 1996 333 337 (Pubitemid 27151739)
7. H. Baran, K. Vass, H. Lassmann, and O. Hornykiewicz The cyclooxygenase and lipoxygenase inhibitor BW755C protects rats against kainic acid-induced seizures and neurotoxicity Brain Res. 646 1994 201 206 (Pubitemid 24151752)
8. J.E. Cavazos, G. Golarai, and T.P. Sutula Mossy fiber synaptic reorganization induced by kindling: time course of development, progression, and permanence J. Neurosci. 11 1991 2795 2803
9. S.H. Choi, S. Aid, and F. Bosetti The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research Trends Pharmacol. Sci. 30 2009 174 181
10. K.K. Cole-Edwards, and N.G. Bazan Lipid signaling in experimental epilepsy Neurochem. Res. 30 2005 847 853 (Pubitemid 41413941)
11. P. Desjardins, A. Sauvageau, A. Bouthillier, D. Navarro, A.S. Hazell, C. Rose, and R.F. Butterworth Induction of astrocytic cyclooxygenase-2 in epileptic patients with hippocampal sclerosis Neurochem. Int. 42 2003 299 303 (Pubitemid 35447667)
12. A. Dhir, P.S. Naidu, and S.K. Kulkarni Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: possible mechanism of action Prog. Neuropsychopharmacol. Biol. Psychiatry 30 2006 1478 1485 (Pubitemid 44634957)
13. S. Flier, and W. Buhre Selective COX-2 inhibitors: new insights into mechanisms of side effects? Crit. Care Med. 36 2008 2694 2695
14. A. Friedman Blood-brain barrier dysfunction, status epilepticus, seizures, and epilepsy: a puzzle of a chicken and egg? Epilepsia 52 Suppl. 8 2011 19 20
15. C.K. Glass, K. Saijo, B. Winner, M.C. Marchetto, and F.H. Gage Mechanisms underlying inflammation in neurodegeneration Cell 140 2010 918 934
16. L. Holtman, E.A. van Vliet, R. van Schaik, C.M. Queiroz, E. Aronica, and J.A. Gorter Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy Epilepsy Res. 84 2009 56 66
17. F.E. Jensen Developmental factors in the pathogenesis of neonatal seizures J. Pediatr. Neurol. 7 2009 5 12
18. S. Jessberger, K. Nakashima, G.D. Clemenson Jr., E. Mejia, E. Mathews, K. Ure, S. Ogawa, C.M. Sinton, F.H. Gage, and J. Hsieh Epigenetic modulation of seizure-induced neurogenesis and cognitive decline J. Neurosci. 27 2007 5967 5975 (Pubitemid 46849752)
19. W. Jiang, Q. Wan, Z.J. Zhang, W.D. Wang, Y.G. Huang, Z.R. Rao, and X. Zhang Dentate granule cell neurogenesis after seizures induced by pentylenetrazol in rats Brain Res. 977 2003 141 148 (Pubitemid 36782470)
20. K.H. Jung, K. Chu, S.T. Lee, J. Kim, D.I. Sinn, J.M. Kim, D.K. Park, J.J. Lee, S.U. Kim, M. Kim, S.K. Lee, and J.K. Roh Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus Neurobiol. Dis. 23 2006 237 246 (Pubitemid 44097031)
21. T. Kunz, and E.H. Oliw The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus Eur. J. Neurosci. 13 2001 569 575 (Pubitemid 32158790)
22. J. Liu, K. Solway, R.O. Messing, and F.R. Sharp Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils J. Neurosci. 18 1998 7768 7778 (Pubitemid 28441018)
23. A. Lleo, E. Galea, and M. Sastre Molecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases Cell Mol. Life Sci. 64 2007 1403 1418 (Pubitemid 46889230)
24. N. Marchi, Q. Fan, C. Ghosh, V. Fazio, F. Bertolini, G. Betto, A. Batra, E. Carlton, I. Najm, T. Granata, and D. Janigro Antagonism of peripheral inflammation reduces the severity of status epilepticus Neurobiol. Dis. 33 2009 171 181
25. M.F. McCarty, and K.I. Block Preadministration of high-dose salicylates, suppressors of NF-kappaB activation, may increase the chemosensitivity of many cancers: an example of proapoptotic signal modulation therapy Integr. Cancer Ther. 5 2006 252 268 (Pubitemid 44154879)
26. K. Okada, T. Yuhi, S. Tsuji, and U. Yamashita Cyclooxygenase-2 expression in the hippocampus of genetically epilepsy susceptible El mice was increased after seizure Brain Res. 894 2001 332 335 (Pubitemid 32217768)
27. M.S. Oliveira, A.F. Furian, L.F. Royes, M.R. Fighera, N.G. Fiorenza, M. Castelli, P. Machado, D. Bohrer, M. Veiga, J. Ferreira, E.A. Cavalheiro, and C.F. Mello Cyclooxygenase-2/PGE2 pathway facilitates pentylenetetrazol-induced seizures Epilepsy Res. 79 2008 14 21
28. E. Perucca, J. French, and M. Bialer Development of new antiepileptic drugs: challenges, incentives, and recent advances Lancet Neurol. 6 2007 793 804 (Pubitemid 47243712)
29. A. Pitkanen, and T.P. Sutula Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy Lancet Neurol. 1 2002 173 181 (Pubitemid 37163486)
30. N. Polascheck, M. Bankstahl, and W. Loscher The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy Exp. Neurol. 224 2010 219 233
31. R.J. Racine Modification of seizure activity by electrical stimulation. II. Motor seizure Electroencephalogr. Clin. Neurophysiol. 32 1972 281 294
32. S.N. Rakhade, and F.E. Jensen Epileptogenesis in the immature brain: emerging mechanisms Nat. Rev. Neurol. 5 2009 380 391
33. T. Ravizza, S. Balosso, and A. Vezzani Inflammation and prevention of epileptogenesis Neurosci. Lett. 497 2011 223 230
34. T. Ravizza, B. Gagliardi, F. Noe, K. Boer, E. Aronica, and A. Vezzani Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy Neurobiol. Dis. 29 2008 142 160 (Pubitemid 350180489)
35. M.A. Rogawski, and W. Loscher The neurobiology of antiepileptic drugs Nat. Rev. Neurosci. 5 2004 553 564 (Pubitemid 38868551)
36. P.M. Rothwell, F.G. Fowkes, J.F. Belch, H. Ogawa, C.P. Warlow, and T.W. Meade Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials Lancet 377 2011 31 41
37. M. Scheepers, A. Pearson, and M. Michaelides Epileptic convulsion following aspirin withdrawal before lid surgery Eye (Lond.) 21 2007 446 (Pubitemid 46358826)
38. L.A. Shapiro, C.E. Ribak, and S. Jessberger Structural changes for adult-born dentate granule cells after status epilepticus Epilepsia 49 Suppl. 5 2008 13 18 (Pubitemid 351782996)
39. D.L. Simmons, R.M. Botting, and T. Hla Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition Pharmacol. Rev. 56 2004 387 437 (Pubitemid 39096597)
40. A.K. Srivastava, and Y.K. Gupta Aspirin modulates the anticonvulsant effect of diazepam and sodium valproate in pentylenetetrazole and maximal electroshock induced seizures in mice Indian J. Physiol. Pharmacol. 45 2001 475 480 (Pubitemid 33026903)
41. T. Takemiya, K. Matsumura, and K. Yamagata Roles of prostaglandin synthesis in excitotoxic brain diseases Neurochem. Int. 51 2007 112 120 (Pubitemid 47176705)
42. S. Tanaka, T. Nakamura, K. Sumitani, F. Takahashi, R. Konishi, T. Itano, and O. Miyamoto Stage- and region-specific cyclooxygenase expression and effects of a selective COX-1 inhibitor in the mouse amygdala kindling model Neurosci. Res. 65 2009 79 87
43. M. Tandon, K. Anuradha, and P. Pandhi Evaluation of antiepileptic activity of aspirin in combination with newer antiepileptic lamotrigine in mice Methods Find. Exp. Clin. Pharmacol. 25 2003 607 610 (Pubitemid 37448675)
44. J.R. Vane, and R.M. Botting The mechanism of action of aspirin Thromb. Res. 110 2003 255 258 (Pubitemid 37329821)
45. J. Varughese Aspirin in heart disease, transient ischemic attacks, and stroke Can. Fam. Physician 35 1989 2083 2085 (Pubitemid 19263083)
46. A. Vezzani, and T.Z. Baram New roles for interleukin-1 beta in the mechanisms of epilepsy Epilepsy Curr. 7 2007 45 50
47. A. Vezzani, J. French, T. Bartfai, and T.Z. Baram The role of inflammation in epilepsy Nat. Rev. Neurol. 7 2011 31 40
48. A. Vezzani, and T. Granata Brain inflammation in epilepsy: experimental and clinical evidence Epilepsia 46 2005 1724 1743 (Pubitemid 44921957)
49. R.S. Wali, and P.A. Patil Aspirin and anticonvulsant interaction Indian J. Physiol. Pharmacol. 39 1995 77 79
50. T.D. Warner, and J.A. Mitchell Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum? Proc. Natl. Acad. Sci. U S A 99 2002 13371 13373 (Pubitemid 35215385)
51. F. Yang, Z.R. Liu, J. Chen, S.J. Zhang, Q.Y. Quan, Y.G. Huang, and W. Jiang Roles of astrocytes and microglia in seizure-induced aberrant neurogenesis in the hippocampus of adult rats J. Neurosci. Res. 88 2010 519 529
52. F. Yang, J.C. Wang, J.L. Han, G. Zhao, and W. Jiang Different effects of mild and severe seizures on hippocampal neurogenesis in adult rats Hippocampus 18 2008 460 468 (Pubitemid 351671405)
53. A. Zandieh, F. Maleki, A. Hajimirzabeigi, B. Zandieh, O. Khalilzadeh, and A.R. Dehpour Anticonvulsant effect of celecoxib on pentylenetetrazole-induced convulsion: modulation by NO pathway Acta Neurobiol. Exp. (Wars) 70 2010 390 397